OUTCOMES OF DIFFUSE LARGE B CELL LYMPHOMA PATIENTS TREATED IN A BRAZILIAN PUBLIC CANCER CENTER ¿ A REAL WORLD EXPERIENCE OF 809 PATIENTS IN A 11 YEAR PERIOD M Bellesso; J Pereira; L Bassolli; ANR Abdo; WFS Junior; RD Velasques; AAGS Brandão; LAPC Lage; FVR Maciel; V Rocha; H Visnadi;

LOW MOLECULAR DIVERSITY AND GENOTYPIC-PROGNOSTIC ASSOCIATIONS IN FOLLICULAR LYMPHOMA (FL): IDENTIFICATION OF NEW BIOLOGICAL MARKERS BY LARGE-SCALE GENE MICROARRAY LAPC Lage; DS Nogueira; CO Reichert; HF Culler; FA Freitas; CR Ferreira; RO Costa; V Rocha; D Levy; J Pereira;

OUTCOMES AND TOXICITY PROFILE IN ELDERLY DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS (DLBCL): A REAL-WORLD AND COMPARATIVE STUDY INVOLVING THREE DIFFERENT DOSE-MODULATED ANTHRACYCLINE-BASED IMMUNOCHEMOTHERAPY REGIMENS IN LATAM LAPC Lage; RN Vita; CO Reichert; HF Culler; FA Freitas; LBO Alves; V Rocha; SAC Siqueira; RO Costa; J Pereira;